2017
DOI: 10.1016/j.yrtph.2017.04.004
|View full text |Cite
|
Sign up to set email alerts
|

Lipid-soluble green tea extract: Genotoxicity and subchronic toxicity studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0
2

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 44 publications
0
10
0
2
Order By: Relevance
“…Finally, it is paramount to validate the most promising in vitro data using in vivo models, like toxicologically treated [54,87] or disease-specific [51,56] rodents that could be fed with the original foods, extracts, or isolated bioactive polyphenol molecules. This is also fundamental in assessing the in vivo side effects of polyphenols, particularly in situations mentioned above, and to ascertain the safe usage of any proposed polyphenol [88][89][90][91]. Ultimately, results of in vitro studies, as well as those from animal models, have to be validated by a human pilot study where the beneficial vs. deleterious effects can be monitored, eventually proceeding to clinical trials [92].…”
Section: Neurotoxicity Vs Neuroprotectionmentioning
confidence: 99%
“…Finally, it is paramount to validate the most promising in vitro data using in vivo models, like toxicologically treated [54,87] or disease-specific [51,56] rodents that could be fed with the original foods, extracts, or isolated bioactive polyphenol molecules. This is also fundamental in assessing the in vivo side effects of polyphenols, particularly in situations mentioned above, and to ascertain the safe usage of any proposed polyphenol [88][89][90][91]. Ultimately, results of in vitro studies, as well as those from animal models, have to be validated by a human pilot study where the beneficial vs. deleterious effects can be monitored, eventually proceeding to clinical trials [92].…”
Section: Neurotoxicity Vs Neuroprotectionmentioning
confidence: 99%
“…Consumption of tea has been reported with few adverse events [127,148,236]. Tumorigenic, mutagenic, teratogenic, and sub-chronic toxicity of tea-related ingredients have not been observed in animal experiments and human studies, and the no-observed-adverse-effect level (NOAEL), observed safety level, and tolerable upper intake level were far from the functional doses [26,222,223,237]. However, some compounds contained in tea has been recognized as anti-nutritive factors.…”
Section: Potential Safety Issuesmentioning
confidence: 99%
“…No deaths or obvious clinical signs no differences in organ weight, body weight gain, and food consumption no changes in biochemical and hematological parameters no lesion-inducing effects in organs (Liu et al, 2017) 0.125, 0.25, and 0.5 g/kg/day for 90 days, gavage…”
Section: Green Tea Extractmentioning
confidence: 99%
“…Another studies revealed the safety of lipid‐soluble GT extract (composed of catechin mono‐, di‐, and tri‐palmitates [66–80%], palmitic acid [12–15%], free catechins, gallic acid, alkaloids [1–2%]) and aqueous extract of tea flowers in rats. Administration of lipid‐soluble extract to rats for 30 (2.3 g/kg/day) and 90 days (0.5 g/kg/day) had no toxic effects (Liu et al, ). Furthermore, the aqueous extract of tea flower was safe up to 4 g/kg/day, for 13 weeks, where its NOAEL reported 4 g/kg/day (Li et al, ).…”
Section: Toxicological Findingsmentioning
confidence: 99%
See 1 more Smart Citation